ADA and neoplasm: To validate the impact of ADA on the immune response, a certain amount of 5′-N-ethylcarboxamidoadenosine (NECA) (an ADO mimic) was introduced into the coincubation system to mimic the conditions within the tumor microenvironment and evaluate DC maturation.